Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2024-12-04

Clinical Trial Update: A Study of a Lifestyle Program on Recurrent Atrial Fibrillation [NA]

View source ↗

Summary

A Mayo Clinic-sponsored clinical trial evaluating a lifestyle program for recurrent atrial fibrillation has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Mayo Clinic | Conditions: Atrial Fibrillation | NA | Status: WITHDRAWN